fa چالش‌ها و راهکارهای مراقبت از بیماری مزمن کلیوی در افراد مبتلا به دیابت نوع 2: نقطه نظر غدد غدد پژوهشي Research <span style="font-size:10pt"><span style="line-height:135%"><span style="direction:rtl"><span style="unicode-bidi:embed"><span new="" roman="" style="font-family:" times=""><span lang="FA" style="font-size:13.0pt"><span style="line-height:135%"><span b="" nazanin="" style="font-family:">شیوع بیماری مزمن کلیوی (</span></span></span><span dir="LTR" style="font-size:11.0pt"><span style="line-height:135%">Chronic kidney disease; CKD</span></span><span lang="FA" style="font-size:13.0pt"><span style="line-height:135%"><span b="" nazanin="" style="font-family:">) در افراد مبتلا به دیابت نوع 2 (</span></span></span><span dir="LTR" style="font-size:11.0pt"><span style="line-height:135%">Type 2 diabetes mellitus; T2DM</span></span><span lang="FA" style="font-size:13.0pt"><span style="line-height:135%"><span b="" nazanin="" style="font-family:">) یک چالش حیاتی است که ارائه دهندگان مراقبت‌های بهداشتی با آن مواجه هستند. اصلاح سبک زندگی، تغییر رژیم غذایی و ورزش منظم، نقش اساسی در پیشگیری از </span></span></span><span dir="LTR" style="font-size:11.0pt"><span style="line-height:135%">CKD</span></span><span lang="FA" style="font-size:13.0pt"><span style="line-height:135%"><span b="" nazanin="" style="font-family:"> در افراد مبتلا به </span></span></span><span dir="LTR" style="font-size:11.0pt"><span style="line-height:135%">T2DM</span></span><span lang="FA" style="font-size:13.0pt"><span style="line-height:135%"><span b="" nazanin="" style="font-family:"> دارند. در کنار مداخلات سبک زندگی، غربال‌گری، تشخیص زودهنگام و سپس درمان‌های دارویی به عنوان ابزاری قدرتمند در برابر بیماری کلیوی دیابتی ظاهر شده‌اند. جهت درمان </span></span></span><span dir="LTR" style="font-size:11.0pt"><span style="line-height:135%">CKD</span></span><span lang="FA" style="font-size:13.0pt"><span style="line-height:135%"><span b="" nazanin="" style="font-family:">، یک رویکرد درمانی متمرکز بر کنترل فشار و گلوکز خون ضروری است. برای بهبود نتایج و کاهش تأثیر مخرب </span></span></span><span dir="LTR" style="font-size:11.0pt"><span style="line-height:135%">CKD</span></span><span lang="FA" style="font-size:13.0pt"><span style="line-height:135%"><span b="" nazanin="" style="font-family:"> در بیماران مبتلا به </span></span></span><span dir="LTR" style="font-size:11.0pt"><span style="line-height:135%">T2DM</span></span><span lang="FA" style="font-size:13.0pt"><span style="line-height:135%"><span b="" nazanin="" style="font-family:">، لازم است که ارائه دهندگان مراقبت‌های بهداشتی در جریان راه‌کارهای جدید برای حفاظت از کلیه‌ها باشند. با اجرای یک رویکرد جامع که از تغییرات سبک زندگی، غربال‌گری به موقع، مداخلات دارویی اثبات شده و عوامل درمانی جدید استفاده می‌کند، می‌توان برای بهبود نتایج تلاش کرد.</span></span></span><span dir="LTR" style="font-size:11.0pt"><span style="line-height:135%"></span></span></span></span></span></span></span><br> <span style="font-size:10pt"><span style="line-height:135%"><span style="direction:rtl"><span style="unicode-bidi:embed"><span new="" roman="" style="font-family:" times=""><b><span lang="FA" style="font-size:13.0pt"><span style="line-height:135%"><span b="" nazanin="" style="font-family:">واژه‌های کلیدی:</span></span></span></b><span lang="FA" style="font-size:13.0pt"><span style="line-height:135%"><span b="" nazanin="" style="font-family:"> بیماری مزمن کلیه، دیابت نوع 2، پیشگیری، غربال‌گری، مداخلات دارویی</span></span></span></span></span></span></span></span><br> &nbsp; <span style="font-size:10pt"><span style="line-height:150%"><span style="tab-stops:-45.0pt"><span style="text-autospace:none"><span new="" roman="" style="font-family:" times=""><a name="_Hlk114425361"><span style="font-size:9.0pt"><span style="line-height:150%">The prevalence of chronic kidney disease (CKD) in people with type 2 diabetes mellitus (T2DM) is a critical challenge that healthcare providers face. Lifestyle modification, dietary changes, and regular exercise are essential in preventing CKD in people with T2DM. Along with lifestyle interventions, screening, early diagnosis, and then drug treatments have emerged as powerful tools against diabetic kidney disease. A therapeutic approach focused on blood pressure and glucose control is essential to treat CKD. To improve outcomes and reduce the detrimental impact of CKD in patients with T2DM, healthcare providers must be aware of new strategies for kidney protection. By implementing a comprehensive approach that uses lifestyle changes, timely screening, proven pharmacological interventions, and new therapeutic agents, we can work to improve outcomes.</span></span></a></span></span></span></span></span><br> <span style="font-size:10pt"><span style="line-height:150%"><span style="tab-stops:-45.0pt"><span style="text-autospace:none"><span new="" roman="" style="font-family:" times=""><b><span style="font-size:9.0pt"><span style="line-height:150%">Key words:</span></span></b><span style="font-size:9.0pt"><span style="line-height:150%"> Chronic kidney disease, Type 2 diabetes, Prevention, Screening, Drug interventions.</span></span></span></span></span></span></span><br> <span style="font-size:10pt"><span style="line-height:150%"><span style="tab-stops:-45.0pt"><span style="text-autospace:none"><span new="" roman="" style="font-family:" times=""><b><span style="font-size:9.0pt"><span style="line-height:150%"></span></span></b></span></span></span></span></span><br> <span style="font-size:10pt"><span style="line-height:150%"><span style="tab-stops:-45.0pt"><span style="text-autospace:none"><span new="" roman="" style="font-family:" times=""><b><span style="font-size:9.0pt"><span style="line-height:150%">Funding:</span></span></b><span style="font-size:9.0pt"><span style="line-height:150%"> None.</span></span></span></span></span></span></span><br> <span style="font-size:10pt"><span style="line-height:150%"><span style="tab-stops:-45.0pt"><span style="text-autospace:none"><span new="" roman="" style="font-family:" times=""><b><span style="font-size:9.0pt"><span style="line-height:150%">Conflict of interest:</span></span></b><span style="font-size:9.0pt"><span style="line-height:150%"> None declared.</span></span></span></span></span></span></span><br> <span style="font-size:10pt"><span style="line-height:150%"><span style="tab-stops:-45.0pt"><span style="text-autospace:none"><span new="" roman="" style="font-family:" times=""><b><span style="font-size:9.0pt"><span style="line-height:150%">Ethical considerations:</span></span></b><span style="font-size:9.0pt"><span style="line-height:150%"> Not applicable.</span></span><b><span style="font-size:9.0pt"><span style="line-height:150%"></span></span></b></span></span></span></span></span><br> <span style="font-size:10pt"><span style="line-height:150%"><span style="tab-stops:-45.0pt"><span style="text-autospace:none"><span new="" roman="" style="font-family:" times=""><b><span style="font-size:9.0pt"><span style="line-height:150%">Authors&rsquo; contributions: </span></span></b></span></span></span></span></span><br> <span style="font-size:10pt"><span style="line-height:150%"><span style="tab-stops:-45.0pt"><span style="text-autospace:none"><span new="" roman="" style="font-family:" times=""><b><span style="font-size:9.0pt"><span style="line-height:150%">- Conceptualization: </span></span></b>Jalal Hasanshahi<b><span style="font-size:9.0pt"><span style="line-height:150%"></span></span></b></span></span></span></span></span><br> <span style="font-size:10pt"><span style="line-height:150%"><span style="tab-stops:-45.0pt"><span style="text-autospace:none"><span new="" roman="" style="font-family:" times=""><b><span style="font-size:9.0pt"><span style="line-height:150%">- Methodology: </span></span></b>Jalal Hasanshahi<b><span style="font-size:9.0pt"><span style="line-height:150%"></span></span></b></span></span></span></span></span><br> <span style="font-size:10pt"><span style="line-height:150%"><span style="tab-stops:-45.0pt"><span style="text-autospace:none"><span new="" roman="" style="font-family:" times=""><b><span style="font-size:9.0pt"><span style="line-height:150%">- Data collection: </span></span></b>Jalal Hasanshahi<b><span style="font-size:9.0pt"><span style="line-height:150%"></span></span></b></span></span></span></span></span><br> <span style="font-size:10pt"><span style="line-height:150%"><span style="tab-stops:-45.0pt"><span style="text-autospace:none"><span new="" roman="" style="font-family:" times=""><b><span style="font-size:9.0pt"><span style="line-height:150%">- Formal analysis:</span></span></b> Jalal Hasanshahi<span style="font-size:8.0pt"><span style="line-height:150%">.</span></span><b><span style="font-size:9.0pt"><span style="line-height:150%"></span></span></b></span></span></span></span></span><br> <span style="font-size:10pt"><span style="line-height:150%"><span style="tab-stops:-45.0pt"><span style="text-autospace:none"><span new="" roman="" style="font-family:" times=""><b><span style="font-size:9.0pt"><span style="line-height:150%">- Supervision: </span></span></b>Jalal Hasanshahi<b><span style="font-size:9.0pt"><span style="line-height:150%"></span></span></b></span></span></span></span></span><br> <span style="font-size:10pt"><span style="line-height:150%"><span style="tab-stops:-45.0pt"><span style="text-autospace:none"><span new="" roman="" style="font-family:" times=""><b><span style="font-size:9.0pt"><span style="line-height:150%">- Project administration: </span></span></b>Jalal Hasanshahi<b><span style="font-size:9.0pt"><span style="line-height:150%"></span></span></b></span></span></span></span></span><br> <span style="font-size:10pt"><span style="line-height:150%"><span style="tab-stops:-45.0pt"><span style="text-autospace:none"><span new="" roman="" style="font-family:" times=""><b><span style="font-size:9.0pt"><span style="line-height:150%">- Writing - original draft: </span></span></b>Jalal Hasanshahi<b><span style="font-size:9.0pt"><span style="line-height:150%"></span></span></b></span></span></span></span></span><br> <span style="font-size:10pt"><span style="line-height:150%"><span style="tab-stops:-45.0pt"><span style="text-autospace:none"><span new="" roman="" style="font-family:" times=""><b><span style="line-height:150%">&nbsp; - </span></b><b><span style="font-size:9.0pt"><span style="line-height:150%">Writing - review and editing:</span></span></b><b> </b>Jalal Hasanshahi<span class="MsoHyperlink" style="color:#0563c1"><span style="text-decoration:underline"></span></span></span></span></span></span></span><br> &nbsp; بیماری مزمن کلیه, دیابت نوع 2, پیشگیری, غربال‌گری, مداخلات دارویی Chronic kidney disease, Type 2 diabetes, Prevention, Screening, Drug interventions. 367 373 http://journal.rums.ac.ir/browse.php?a_code=A-10-1742-6&slc_lang=fa&sid=1 Jalal Hassanshahi جلال حسن شاهی hasanshahij@gmail.com 6900319475328460058376 6900319475328460058376 Yes Rafsanjan University of Medical Sciences دانشگاه علوم پزشکی رفسنجان، رفسنجان